PerkinElmer is slimming down to focus solely on diagnostics and life sciences research, selling off its other businesses in a deal that will hand it $2.3 billion in cash. The funding is expected to ...

A new hub designed to bring customers, applications, and real-time process insight together to turn analytical science ...

A month has gone by since the last earnings report for PerkinElmer (PKI). Shares have lost about 11.6% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Nine months after announcing it ...

PerkinElmer is acquiring Covaris, which manufactures applications and solutions for life science companies, as part of an effort to expand its life sciences portfolio. The biotech announced Monday ...

The stock price of PerkinElmer Inc. (NYSE: PKI), a Waltham-based company focused on diagnostics, life sciences, and applied services markets, is up roughly 2x from the levels it was at on March 23, ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE - In this Feb. 11, 2021, file photo is the exterior of the PerkinElmer lab in Valencia, Calif. PerkinElmer will spend about ...

PerkinElmer's shares have risen more than 47% in 2020, so why isn't everyone talking about this fast-rising testing company? PerkinElmer sells high-end laboratory equipment like mass spectrometers and ...

PerkinElmer said today it agreed to acquire BioLegend, a provider of life science antibodies and reagents, for approximately $5.25 billion in cash and stock—the largest acquisition in the buyer’s ...